nodes	percent_of_prediction	percent_of_DWPC	metapath
Diazoxide—Cerebral ischaemia—Vandetanib—thyroid cancer	0.031	0.0497	CcSEcCtD
Diazoxide—GLUL—neck—thyroid cancer	0.0269	0.0864	CbGeAlD
Diazoxide—Haemoglobin decreased—Vandetanib—thyroid cancer	0.0218	0.0349	CcSEcCtD
Diazoxide—Ileus—Vandetanib—thyroid cancer	0.0212	0.0339	CcSEcCtD
Diazoxide—GLUL—saliva-secreting gland—thyroid cancer	0.021	0.0674	CbGeAlD
Diazoxide—Nephrotic syndrome—Sorafenib—thyroid cancer	0.0209	0.0335	CcSEcCtD
Diazoxide—KCNMA1—saliva-secreting gland—thyroid cancer	0.0195	0.0625	CbGeAlD
Diazoxide—GLUL—trachea—thyroid cancer	0.0162	0.052	CbGeAlD
Diazoxide—ATP1A1—neck—thyroid cancer	0.0161	0.0515	CbGeAlD
Diazoxide—Cataract—Vandetanib—thyroid cancer	0.0157	0.0252	CcSEcCtD
Diazoxide—Haemoglobin decreased—Sorafenib—thyroid cancer	0.0147	0.0235	CcSEcCtD
Diazoxide—GLUL—thyroid gland—thyroid cancer	0.0128	0.0411	CbGeAlD
Diazoxide—ATP1A1—saliva-secreting gland—thyroid cancer	0.0125	0.0402	CbGeAlD
Diazoxide—CA2—neck—thyroid cancer	0.0123	0.0395	CbGeAlD
Diazoxide—KCNJ11—thyroid gland—thyroid cancer	0.012	0.0386	CbGeAlD
Diazoxide—KCNMA1—thyroid gland—thyroid cancer	0.0119	0.0382	CbGeAlD
Diazoxide—Polyneuropathy—Epirubicin—thyroid cancer	0.0115	0.0184	CcSEcCtD
Diazoxide—GLUL—head—thyroid cancer	0.0114	0.0365	CbGeAlD
Diazoxide—ABCC8—thyroid gland—thyroid cancer	0.0111	0.0355	CbGeAlD
Diazoxide—Drug interaction—Sorafenib—thyroid cancer	0.0109	0.0175	CcSEcCtD
Diazoxide—KCNJ11—head—thyroid cancer	0.0107	0.0342	CbGeAlD
Diazoxide—Polyneuropathy—Doxorubicin—thyroid cancer	0.0106	0.017	CcSEcCtD
Diazoxide—KCNMA1—head—thyroid cancer	0.0106	0.0338	CbGeAlD
Diazoxide—Hypokalaemia—Vandetanib—thyroid cancer	0.00989	0.0159	CcSEcCtD
Diazoxide—ABCC8—head—thyroid cancer	0.00984	0.0315	CbGeAlD
Diazoxide—ATP1A1—trachea—thyroid cancer	0.00966	0.031	CbGeAlD
Diazoxide—CA2—saliva-secreting gland—thyroid cancer	0.0096	0.0308	CbGeAlD
Diazoxide—Pancreatitis—Vandetanib—thyroid cancer	0.00921	0.0148	CcSEcCtD
Diazoxide—Hyperglycaemia—Vandetanib—thyroid cancer	0.00848	0.0136	CcSEcCtD
Diazoxide—CA1—head—thyroid cancer	0.00802	0.0257	CbGeAlD
Diazoxide—Haematuria—Vandetanib—thyroid cancer	0.00799	0.0128	CcSEcCtD
Diazoxide—GLUL—lymph node—thyroid cancer	0.00796	0.0255	CbGeAlD
Diazoxide—ATP1A1—thyroid gland—thyroid cancer	0.00764	0.0245	CbGeAlD
Diazoxide—Haemoglobin—Vandetanib—thyroid cancer	0.00756	0.0121	CcSEcCtD
Diazoxide—Haemorrhage—Vandetanib—thyroid cancer	0.00752	0.0121	CcSEcCtD
Diazoxide—KCNJ11—lymph node—thyroid cancer	0.00748	0.024	CbGeAlD
Diazoxide—CA2—trachea—thyroid cancer	0.0074	0.0237	CbGeAlD
Diazoxide—KCNMA1—lymph node—thyroid cancer	0.00739	0.0237	CbGeAlD
Diazoxide—ATP1A1—head—thyroid cancer	0.00678	0.0217	CbGeAlD
Diazoxide—Hypokalaemia—Sorafenib—thyroid cancer	0.00667	0.0107	CcSEcCtD
Diazoxide—Aspartate aminotransferase increased—Sorafenib—thyroid cancer	0.0066	0.0106	CcSEcCtD
Diazoxide—Lacrimation—Epirubicin—thyroid cancer	0.00635	0.0102	CcSEcCtD
Diazoxide—Pancreatitis—Sorafenib—thyroid cancer	0.00621	0.00996	CcSEcCtD
Diazoxide—Vision blurred—Vandetanib—thyroid cancer	0.00617	0.00989	CcSEcCtD
Diazoxide—Abdominal discomfort—Sorafenib—thyroid cancer	0.00608	0.00974	CcSEcCtD
Diazoxide—Lacrimation—Doxorubicin—thyroid cancer	0.00587	0.00942	CcSEcCtD
Diazoxide—CA2—thyroid gland—thyroid cancer	0.00586	0.0188	CbGeAlD
Diazoxide—Hypertension—Vandetanib—thyroid cancer	0.00565	0.00906	CcSEcCtD
Diazoxide—CA1—lymph node—thyroid cancer	0.00561	0.018	CbGeAlD
Diazoxide—Chest pain—Vandetanib—thyroid cancer	0.00557	0.00893	CcSEcCtD
Diazoxide—Anxiety—Vandetanib—thyroid cancer	0.00555	0.0089	CcSEcCtD
Diazoxide—Oedema—Vandetanib—thyroid cancer	0.00534	0.00856	CcSEcCtD
Diazoxide—ATP1A1—Preimplantation Embryo—NKX2-1—thyroid cancer	0.00531	0.0826	CbGpPWpGaD
Diazoxide—Ileus—Epirubicin—thyroid cancer	0.00527	0.00845	CcSEcCtD
Diazoxide—Thrombocytopenia—Vandetanib—thyroid cancer	0.00523	0.00838	CcSEcCtD
Diazoxide—CA2—head—thyroid cancer	0.0052	0.0167	CbGeAlD
Diazoxide—Haemoglobin—Sorafenib—thyroid cancer	0.0051	0.00817	CcSEcCtD
Diazoxide—Haemorrhage—Sorafenib—thyroid cancer	0.00507	0.00813	CcSEcCtD
Diazoxide—Albuminuria—Epirubicin—thyroid cancer	0.005	0.00801	CcSEcCtD
Diazoxide—Scotoma—Epirubicin—thyroid cancer	0.00492	0.00788	CcSEcCtD
Diazoxide—Ileus—Doxorubicin—thyroid cancer	0.00488	0.00782	CcSEcCtD
Diazoxide—Insomnia—Vandetanib—thyroid cancer	0.00483	0.00775	CcSEcCtD
Diazoxide—Paraesthesia—Vandetanib—thyroid cancer	0.0048	0.00769	CcSEcCtD
Diazoxide—Feeling hot—Epirubicin—thyroid cancer	0.00476	0.00762	CcSEcCtD
Diazoxide—ATP1A1—lymph node—thyroid cancer	0.00475	0.0152	CbGeAlD
Diazoxide—Flushing—Sorafenib—thyroid cancer	0.00471	0.00755	CcSEcCtD
Diazoxide—ATP1A1—Preimplantation Embryo—TCF7L1—thyroid cancer	0.00467	0.0727	CbGpPWpGaD
Diazoxide—Decreased appetite—Vandetanib—thyroid cancer	0.00464	0.00744	CcSEcCtD
Diazoxide—Albuminuria—Doxorubicin—thyroid cancer	0.00463	0.00742	CcSEcCtD
Diazoxide—Glycosuria—Epirubicin—thyroid cancer	0.00461	0.00739	CcSEcCtD
Diazoxide—Ageusia—Epirubicin—thyroid cancer	0.00461	0.00739	CcSEcCtD
Diazoxide—Pain—Vandetanib—thyroid cancer	0.00457	0.00732	CcSEcCtD
Diazoxide—Scotoma—Doxorubicin—thyroid cancer	0.00455	0.00729	CcSEcCtD
Diazoxide—ABCC8—FOXA2 and FOXA3 transcription factor networks—NKX2-1—thyroid cancer	0.00446	0.0695	CbGpPWpGaD
Diazoxide—Feeling hot—Doxorubicin—thyroid cancer	0.0044	0.00705	CcSEcCtD
Diazoxide—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00437	0.007	CcSEcCtD
Diazoxide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—NKX2-1—thyroid cancer	0.00433	0.0674	CbGpPWpGaD
Diazoxide—Ageusia—Doxorubicin—thyroid cancer	0.00426	0.00683	CcSEcCtD
Diazoxide—Glycosuria—Doxorubicin—thyroid cancer	0.00426	0.00683	CcSEcCtD
Diazoxide—Abdominal pain—Vandetanib—thyroid cancer	0.00422	0.00677	CcSEcCtD
Diazoxide—Body temperature increased—Vandetanib—thyroid cancer	0.00422	0.00677	CcSEcCtD
Diazoxide—Lacrimation increased—Epirubicin—thyroid cancer	0.00405	0.00649	CcSEcCtD
Diazoxide—Leukopenia—Sorafenib—thyroid cancer	0.00395	0.00634	CcSEcCtD
Diazoxide—Asthenia—Vandetanib—thyroid cancer	0.00383	0.00614	CcSEcCtD
Diazoxide—Hypertension—Sorafenib—thyroid cancer	0.00381	0.00611	CcSEcCtD
Diazoxide—Pruritus—Vandetanib—thyroid cancer	0.00378	0.00606	CcSEcCtD
Diazoxide—Lacrimation increased—Doxorubicin—thyroid cancer	0.00375	0.00601	CcSEcCtD
Diazoxide—Diarrhoea—Vandetanib—thyroid cancer	0.00366	0.00586	CcSEcCtD
Diazoxide—CA2—lymph node—thyroid cancer	0.00364	0.0117	CbGeAlD
Diazoxide—Fluid retention—Epirubicin—thyroid cancer	0.00354	0.00568	CcSEcCtD
Diazoxide—Dizziness—Vandetanib—thyroid cancer	0.00353	0.00566	CcSEcCtD
Diazoxide—Thrombocytopenia—Sorafenib—thyroid cancer	0.00353	0.00566	CcSEcCtD
Diazoxide—Anorexia—Sorafenib—thyroid cancer	0.00344	0.00551	CcSEcCtD
Diazoxide—Vomiting—Vandetanib—thyroid cancer	0.0034	0.00544	CcSEcCtD
Diazoxide—Rash—Vandetanib—thyroid cancer	0.00337	0.0054	CcSEcCtD
Diazoxide—Dermatitis—Vandetanib—thyroid cancer	0.00337	0.00539	CcSEcCtD
Diazoxide—Headache—Vandetanib—thyroid cancer	0.00335	0.00536	CcSEcCtD
Diazoxide—Fluid retention—Doxorubicin—thyroid cancer	0.00328	0.00526	CcSEcCtD
Diazoxide—Lymphadenopathy—Epirubicin—thyroid cancer	0.00318	0.00509	CcSEcCtD
Diazoxide—Nausea—Vandetanib—thyroid cancer	0.00317	0.00509	CcSEcCtD
Diazoxide—Decreased appetite—Sorafenib—thyroid cancer	0.00313	0.00502	CcSEcCtD
Diazoxide—Pain—Sorafenib—thyroid cancer	0.00308	0.00494	CcSEcCtD
Diazoxide—Vascular purpura—Epirubicin—thyroid cancer	0.00303	0.00486	CcSEcCtD
Diazoxide—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00295	0.00472	CcSEcCtD
Diazoxide—Lymphadenopathy—Doxorubicin—thyroid cancer	0.00294	0.00471	CcSEcCtD
Diazoxide—Body temperature increased—Sorafenib—thyroid cancer	0.00285	0.00457	CcSEcCtD
Diazoxide—Abdominal pain—Sorafenib—thyroid cancer	0.00285	0.00457	CcSEcCtD
Diazoxide—Purpura—Epirubicin—thyroid cancer	0.00281	0.00451	CcSEcCtD
Diazoxide—Vascular purpura—Doxorubicin—thyroid cancer	0.0028	0.00449	CcSEcCtD
Diazoxide—Diplopia—Epirubicin—thyroid cancer	0.00271	0.00434	CcSEcCtD
Diazoxide—Hypersensitivity—Sorafenib—thyroid cancer	0.00266	0.00426	CcSEcCtD
Diazoxide—Purpura—Doxorubicin—thyroid cancer	0.0026	0.00417	CcSEcCtD
Diazoxide—Asthenia—Sorafenib—thyroid cancer	0.00259	0.00414	CcSEcCtD
Diazoxide—Pruritus—Sorafenib—thyroid cancer	0.00255	0.00409	CcSEcCtD
Diazoxide—Diplopia—Doxorubicin—thyroid cancer	0.00251	0.00402	CcSEcCtD
Diazoxide—Hypokalaemia—Epirubicin—thyroid cancer	0.00247	0.00395	CcSEcCtD
Diazoxide—Diarrhoea—Sorafenib—thyroid cancer	0.00247	0.00395	CcSEcCtD
Diazoxide—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00244	0.00391	CcSEcCtD
Diazoxide—Dizziness—Sorafenib—thyroid cancer	0.00238	0.00382	CcSEcCtD
Diazoxide—Eosinophilia—Epirubicin—thyroid cancer	0.00232	0.00372	CcSEcCtD
Diazoxide—Pancreatitis—Epirubicin—thyroid cancer	0.0023	0.00368	CcSEcCtD
Diazoxide—Vomiting—Sorafenib—thyroid cancer	0.00229	0.00367	CcSEcCtD
Diazoxide—Hypokalaemia—Doxorubicin—thyroid cancer	0.00228	0.00366	CcSEcCtD
Diazoxide—Rash—Sorafenib—thyroid cancer	0.00227	0.00364	CcSEcCtD
Diazoxide—Dermatitis—Sorafenib—thyroid cancer	0.00227	0.00364	CcSEcCtD
Diazoxide—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.00226	0.00362	CcSEcCtD
Diazoxide—Headache—Sorafenib—thyroid cancer	0.00226	0.00362	CcSEcCtD
Diazoxide—Eosinophilia—Doxorubicin—thyroid cancer	0.00215	0.00344	CcSEcCtD
Diazoxide—Nausea—Sorafenib—thyroid cancer	0.00214	0.00343	CcSEcCtD
Diazoxide—Weight increased—Epirubicin—thyroid cancer	0.00213	0.00342	CcSEcCtD
Diazoxide—Pancreatitis—Doxorubicin—thyroid cancer	0.00212	0.00341	CcSEcCtD
Diazoxide—Hyperglycaemia—Epirubicin—thyroid cancer	0.00211	0.00339	CcSEcCtD
Diazoxide—Sweating—Epirubicin—thyroid cancer	0.002	0.00321	CcSEcCtD
Diazoxide—Haematuria—Epirubicin—thyroid cancer	0.00199	0.00319	CcSEcCtD
Diazoxide—Weight increased—Doxorubicin—thyroid cancer	0.00197	0.00316	CcSEcCtD
Diazoxide—Hyperglycaemia—Doxorubicin—thyroid cancer	0.00195	0.00313	CcSEcCtD
Diazoxide—Haemoglobin—Epirubicin—thyroid cancer	0.00188	0.00302	CcSEcCtD
Diazoxide—Haemorrhage—Epirubicin—thyroid cancer	0.00187	0.003	CcSEcCtD
Diazoxide—KCNMA1—Circadian rythm related genes—NKX2-1—thyroid cancer	0.00186	0.029	CbGpPWpGaD
Diazoxide—Sweating—Doxorubicin—thyroid cancer	0.00185	0.00297	CcSEcCtD
Diazoxide—Haematuria—Doxorubicin—thyroid cancer	0.00184	0.00295	CcSEcCtD
Diazoxide—ABCC8—Regulation of insulin secretion—PRKAR1A—thyroid cancer	0.00181	0.0281	CbGpPWpGaD
Diazoxide—KCNJ11—Regulation of insulin secretion—PRKAR1A—thyroid cancer	0.00175	0.0273	CbGpPWpGaD
Diazoxide—Haemoglobin—Doxorubicin—thyroid cancer	0.00174	0.00279	CcSEcCtD
Diazoxide—Flushing—Epirubicin—thyroid cancer	0.00174	0.00279	CcSEcCtD
Diazoxide—Haemorrhage—Doxorubicin—thyroid cancer	0.00173	0.00278	CcSEcCtD
Diazoxide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—thyroid cancer	0.00172	0.0269	CbGpPWpGaD
Diazoxide—Flushing—Doxorubicin—thyroid cancer	0.00161	0.00258	CcSEcCtD
Diazoxide—Vision blurred—Epirubicin—thyroid cancer	0.00154	0.00247	CcSEcCtD
Diazoxide—Ill-defined disorder—Epirubicin—thyroid cancer	0.00151	0.00243	CcSEcCtD
Diazoxide—Malaise—Epirubicin—thyroid cancer	0.00147	0.00236	CcSEcCtD
Diazoxide—Leukopenia—Epirubicin—thyroid cancer	0.00146	0.00234	CcSEcCtD
Diazoxide—Palpitations—Epirubicin—thyroid cancer	0.00144	0.00231	CcSEcCtD
Diazoxide—Vision blurred—Doxorubicin—thyroid cancer	0.00142	0.00228	CcSEcCtD
Diazoxide—ABCC8—Integration of energy metabolism—PRKAR1A—thyroid cancer	0.00142	0.0221	CbGpPWpGaD
Diazoxide—Hypertension—Epirubicin—thyroid cancer	0.00141	0.00226	CcSEcCtD
Diazoxide—Ill-defined disorder—Doxorubicin—thyroid cancer	0.0014	0.00225	CcSEcCtD
Diazoxide—Chest pain—Epirubicin—thyroid cancer	0.00139	0.00223	CcSEcCtD
Diazoxide—Anxiety—Epirubicin—thyroid cancer	0.00138	0.00222	CcSEcCtD
Diazoxide—KCNJ11—Integration of energy metabolism—PRKAR1A—thyroid cancer	0.00138	0.0215	CbGpPWpGaD
Diazoxide—Discomfort—Epirubicin—thyroid cancer	0.00137	0.0022	CcSEcCtD
Diazoxide—Malaise—Doxorubicin—thyroid cancer	0.00136	0.00218	CcSEcCtD
Diazoxide—Leukopenia—Doxorubicin—thyroid cancer	0.00135	0.00217	CcSEcCtD
Diazoxide—Palpitations—Doxorubicin—thyroid cancer	0.00133	0.00214	CcSEcCtD
Diazoxide—Oedema—Epirubicin—thyroid cancer	0.00133	0.00213	CcSEcCtD
Diazoxide—GLUL—Amino acid and derivative metabolism—SLC5A5—thyroid cancer	0.00132	0.0205	CbGpPWpGaD
Diazoxide—Thrombocytopenia—Epirubicin—thyroid cancer	0.0013	0.00209	CcSEcCtD
Diazoxide—Hypertension—Doxorubicin—thyroid cancer	0.0013	0.00209	CcSEcCtD
Diazoxide—Tachycardia—Epirubicin—thyroid cancer	0.0013	0.00208	CcSEcCtD
Diazoxide—Hyperhidrosis—Epirubicin—thyroid cancer	0.00129	0.00206	CcSEcCtD
Diazoxide—Chest pain—Doxorubicin—thyroid cancer	0.00129	0.00206	CcSEcCtD
Diazoxide—Anxiety—Doxorubicin—thyroid cancer	0.00128	0.00205	CcSEcCtD
Diazoxide—Discomfort—Doxorubicin—thyroid cancer	0.00127	0.00204	CcSEcCtD
Diazoxide—Anorexia—Epirubicin—thyroid cancer	0.00127	0.00203	CcSEcCtD
Diazoxide—Hypotension—Epirubicin—thyroid cancer	0.00124	0.00199	CcSEcCtD
Diazoxide—Oedema—Doxorubicin—thyroid cancer	0.00123	0.00198	CcSEcCtD
Diazoxide—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00121	0.00193	CcSEcCtD
Diazoxide—Insomnia—Epirubicin—thyroid cancer	0.0012	0.00193	CcSEcCtD
Diazoxide—Tachycardia—Doxorubicin—thyroid cancer	0.0012	0.00193	CcSEcCtD
Diazoxide—Paraesthesia—Epirubicin—thyroid cancer	0.0012	0.00192	CcSEcCtD
Diazoxide—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00119	0.00191	CcSEcCtD
Diazoxide—Anorexia—Doxorubicin—thyroid cancer	0.00117	0.00188	CcSEcCtD
Diazoxide—Decreased appetite—Epirubicin—thyroid cancer	0.00116	0.00186	CcSEcCtD
Diazoxide—Hypotension—Doxorubicin—thyroid cancer	0.00115	0.00185	CcSEcCtD
Diazoxide—Pain—Epirubicin—thyroid cancer	0.00114	0.00183	CcSEcCtD
Diazoxide—Insomnia—Doxorubicin—thyroid cancer	0.00111	0.00179	CcSEcCtD
Diazoxide—Paraesthesia—Doxorubicin—thyroid cancer	0.00111	0.00177	CcSEcCtD
Diazoxide—Feeling abnormal—Epirubicin—thyroid cancer	0.0011	0.00176	CcSEcCtD
Diazoxide—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00109	0.00175	CcSEcCtD
Diazoxide—Decreased appetite—Doxorubicin—thyroid cancer	0.00107	0.00172	CcSEcCtD
Diazoxide—Pain—Doxorubicin—thyroid cancer	0.00105	0.00169	CcSEcCtD
Diazoxide—Abdominal pain—Epirubicin—thyroid cancer	0.00105	0.00169	CcSEcCtD
Diazoxide—Body temperature increased—Epirubicin—thyroid cancer	0.00105	0.00169	CcSEcCtD
Diazoxide—SLC12A3—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00103	0.016	CbGpPWpGaD
Diazoxide—SLC12A3—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00103	0.016	CbGpPWpGaD
Diazoxide—Feeling abnormal—Doxorubicin—thyroid cancer	0.00102	0.00163	CcSEcCtD
Diazoxide—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00101	0.00162	CcSEcCtD
Diazoxide—Hypersensitivity—Epirubicin—thyroid cancer	0.000981	0.00157	CcSEcCtD
Diazoxide—Abdominal pain—Doxorubicin—thyroid cancer	0.000974	0.00156	CcSEcCtD
Diazoxide—Body temperature increased—Doxorubicin—thyroid cancer	0.000974	0.00156	CcSEcCtD
Diazoxide—Asthenia—Epirubicin—thyroid cancer	0.000956	0.00153	CcSEcCtD
Diazoxide—Pruritus—Epirubicin—thyroid cancer	0.000942	0.00151	CcSEcCtD
Diazoxide—Diarrhoea—Epirubicin—thyroid cancer	0.000911	0.00146	CcSEcCtD
Diazoxide—Hypersensitivity—Doxorubicin—thyroid cancer	0.000908	0.00146	CcSEcCtD
Diazoxide—Asthenia—Doxorubicin—thyroid cancer	0.000884	0.00142	CcSEcCtD
Diazoxide—Dizziness—Epirubicin—thyroid cancer	0.000881	0.00141	CcSEcCtD
Diazoxide—GLUL—Metabolism—MINPP1—thyroid cancer	0.000874	0.0136	CbGpPWpGaD
Diazoxide—Pruritus—Doxorubicin—thyroid cancer	0.000872	0.0014	CcSEcCtD
Diazoxide—Vomiting—Epirubicin—thyroid cancer	0.000847	0.00136	CcSEcCtD
Diazoxide—Diarrhoea—Doxorubicin—thyroid cancer	0.000843	0.00135	CcSEcCtD
Diazoxide—Rash—Epirubicin—thyroid cancer	0.00084	0.00135	CcSEcCtD
Diazoxide—Dermatitis—Epirubicin—thyroid cancer	0.000839	0.00134	CcSEcCtD
Diazoxide—Headache—Epirubicin—thyroid cancer	0.000834	0.00134	CcSEcCtD
Diazoxide—Dizziness—Doxorubicin—thyroid cancer	0.000815	0.00131	CcSEcCtD
Diazoxide—Nausea—Epirubicin—thyroid cancer	0.000791	0.00127	CcSEcCtD
Diazoxide—Vomiting—Doxorubicin—thyroid cancer	0.000784	0.00126	CcSEcCtD
Diazoxide—Rash—Doxorubicin—thyroid cancer	0.000777	0.00125	CcSEcCtD
Diazoxide—Dermatitis—Doxorubicin—thyroid cancer	0.000776	0.00124	CcSEcCtD
Diazoxide—Headache—Doxorubicin—thyroid cancer	0.000772	0.00124	CcSEcCtD
Diazoxide—SLC12A3—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000771	0.012	CbGpPWpGaD
Diazoxide—GLUL—TNF alpha Signaling Pathway—NRAS—thyroid cancer	0.000758	0.0118	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—NDUFA13—thyroid cancer	0.000743	0.0116	CbGpPWpGaD
Diazoxide—Nausea—Doxorubicin—thyroid cancer	0.000732	0.00117	CcSEcCtD
Diazoxide—GLUL—Metabolism—CHST14—thyroid cancer	0.000698	0.0109	CbGpPWpGaD
Diazoxide—GLUL—TNF alpha Signaling Pathway—KRAS—thyroid cancer	0.000653	0.0102	CbGpPWpGaD
Diazoxide—GLUL—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000648	0.0101	CbGpPWpGaD
Diazoxide—CA1—C-MYB transcription factor network—PTGS2—thyroid cancer	0.00063	0.00981	CbGpPWpGaD
Diazoxide—CA1—C-MYB transcription factor network—CCND1—thyroid cancer	0.000569	0.00886	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—PRKAR1A—thyroid cancer	0.000564	0.00878	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—HPGD—thyroid cancer	0.000563	0.00876	CbGpPWpGaD
Diazoxide—GLUL—TNF alpha Signaling Pathway—HRAS—thyroid cancer	0.000555	0.00863	CbGpPWpGaD
Diazoxide—CA2—Metabolism—MINPP1—thyroid cancer	0.000548	0.00853	CbGpPWpGaD
Diazoxide—CA1—Metabolism—MINPP1—thyroid cancer	0.000525	0.00817	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—CP—thyroid cancer	0.000523	0.00815	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000523	0.00815	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000523	0.00815	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000523	0.00815	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000515	0.00801	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000515	0.00801	CbGpPWpGaD
Diazoxide—GLUL—Neuronal System—BRAF—thyroid cancer	0.000497	0.00773	CbGpPWpGaD
Diazoxide—CA1—C-MYB transcription factor network—NRAS—thyroid cancer	0.00049	0.00763	CbGpPWpGaD
Diazoxide—GLUL—TNF alpha Signaling Pathway—AKT1—thyroid cancer	0.00049	0.00762	CbGpPWpGaD
Diazoxide—KCNMA1—Circadian rythm related genes—PPARG—thyroid cancer	0.000476	0.00741	CbGpPWpGaD
Diazoxide—CA2—Metabolism—NDUFA13—thyroid cancer	0.000466	0.00725	CbGpPWpGaD
Diazoxide—ABCC8—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	0.000452	0.00703	CbGpPWpGaD
Diazoxide—CA1—Metabolism—NDUFA13—thyroid cancer	0.000446	0.00695	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—MINPP1—thyroid cancer	0.000446	0.00695	CbGpPWpGaD
Diazoxide—CA2—Metabolism—CHST14—thyroid cancer	0.000438	0.00682	CbGpPWpGaD
Diazoxide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	0.000438	0.00682	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—MINPP1—thyroid cancer	0.000433	0.00674	CbGpPWpGaD
Diazoxide—CA1—C-MYB transcription factor network—KRAS—thyroid cancer	0.000422	0.00657	CbGpPWpGaD
Diazoxide—CA1—Metabolism—CHST14—thyroid cancer	0.00042	0.00654	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000392	0.0061	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000392	0.0061	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—NDUFA13—thyroid cancer	0.00038	0.00591	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—IFNA2—thyroid cancer	0.000373	0.00581	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—NDUFA13—thyroid cancer	0.000368	0.00573	CbGpPWpGaD
Diazoxide—CA1—C-MYB transcription factor network—HRAS—thyroid cancer	0.000359	0.00558	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—CHST14—thyroid cancer	0.000357	0.00556	CbGpPWpGaD
Diazoxide—KCNMA1—Neuronal System—BRAF—thyroid cancer	0.000357	0.00555	CbGpPWpGaD
Diazoxide—CA2—Metabolism—HPGD—thyroid cancer	0.000353	0.00549	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—CP—thyroid cancer	0.000353	0.00549	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000353	0.00549	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000347	0.0054	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—CHST14—thyroid cancer	0.000346	0.00539	CbGpPWpGaD
Diazoxide—CA1—Metabolism—HPGD—thyroid cancer	0.000338	0.00527	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000329	0.00512	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000329	0.00512	CbGpPWpGaD
Diazoxide—KCNMA1—Circadian rythm related genes—PTEN—thyroid cancer	0.000327	0.00509	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—TPR—thyroid cancer	0.000323	0.00503	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PRKAR1A—thyroid cancer	0.000318	0.00495	CbGpPWpGaD
Diazoxide—GLUL—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000298	0.00464	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—HPGD—thyroid cancer	0.000288	0.00448	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—HPGD—thyroid cancer	0.000279	0.00434	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000264	0.00411	CbGpPWpGaD
Diazoxide—ABCC8—Neuronal System—BRAF—thyroid cancer	0.000254	0.00395	CbGpPWpGaD
Diazoxide—KCNJ11—Neuronal System—BRAF—thyroid cancer	0.000246	0.00383	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—SLC5A5—thyroid cancer	0.000242	0.00377	CbGpPWpGaD
Diazoxide—GLUL—Neuronal System—HRAS—thyroid cancer	0.000228	0.00355	CbGpPWpGaD
Diazoxide—KCNMA1—Circadian rythm related genes—TP53—thyroid cancer	0.000223	0.00347	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000222	0.00345	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—RXRA—thyroid cancer	0.000203	0.00317	CbGpPWpGaD
Diazoxide—CA2—Metabolism—TPR—thyroid cancer	0.000203	0.00316	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PRKAR1A—thyroid cancer	0.000199	0.0031	CbGpPWpGaD
Diazoxide—CA1—Metabolism—TPR—thyroid cancer	0.000194	0.00303	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PRKAR1A—thyroid cancer	0.000191	0.00298	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—TPR—thyroid cancer	0.000165	0.00257	CbGpPWpGaD
Diazoxide—KCNMA1—Neuronal System—HRAS—thyroid cancer	0.000164	0.00255	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PRKAR1A—thyroid cancer	0.000163	0.00253	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—TPR—thyroid cancer	0.00016	0.00249	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PRKAR1A—thyroid cancer	0.000158	0.00245	CbGpPWpGaD
Diazoxide—CA2—Metabolism—SLC5A5—thyroid cancer	0.000152	0.00236	CbGpPWpGaD
Diazoxide—CA1—Metabolism—SLC5A5—thyroid cancer	0.000145	0.00226	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—NRAS—thyroid cancer	0.000139	0.00217	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PPARG—thyroid cancer	0.000128	0.002	CbGpPWpGaD
Diazoxide—CA2—Metabolism—RXRA—thyroid cancer	0.000127	0.00198	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—SLC5A5—thyroid cancer	0.000124	0.00193	CbGpPWpGaD
Diazoxide—CA1—Metabolism—RXRA—thyroid cancer	0.000122	0.0019	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—SLC5A5—thyroid cancer	0.00012	0.00187	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—KRAS—thyroid cancer	0.00012	0.00187	CbGpPWpGaD
Diazoxide—ABCC8—Neuronal System—HRAS—thyroid cancer	0.000117	0.00182	CbGpPWpGaD
Diazoxide—KCNJ11—Neuronal System—HRAS—thyroid cancer	0.000113	0.00176	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—TP53—thyroid cancer	0.000107	0.00166	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—RXRA—thyroid cancer	0.000104	0.00162	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—HRAS—thyroid cancer	0.000102	0.00159	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PTGS2—thyroid cancer	0.000101	0.00157	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—RXRA—thyroid cancer	0.000101	0.00157	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—AKT1—thyroid cancer	9e-05	0.0014	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PTEN—thyroid cancer	8.81e-05	0.00137	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PPARG—thyroid cancer	8.05e-05	0.00125	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PPARG—thyroid cancer	7.72e-05	0.0012	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PPARG—thyroid cancer	6.56e-05	0.00102	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PPARG—thyroid cancer	6.36e-05	0.000991	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PTGS2—thyroid cancer	6.33e-05	0.000986	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PTGS2—thyroid cancer	6.07e-05	0.000945	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PTEN—thyroid cancer	5.52e-05	0.00086	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PTEN—thyroid cancer	5.29e-05	0.000824	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PTGS2—thyroid cancer	5.16e-05	0.000804	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—AKT1—thyroid cancer	5.08e-05	0.00079	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PTGS2—thyroid cancer	5.01e-05	0.000779	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PTEN—thyroid cancer	4.5e-05	0.000701	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PTEN—thyroid cancer	4.37e-05	0.00068	CbGpPWpGaD
Diazoxide—CA2—Metabolism—AKT1—thyroid cancer	3.18e-05	0.000495	CbGpPWpGaD
Diazoxide—CA1—Metabolism—AKT1—thyroid cancer	3.05e-05	0.000475	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—AKT1—thyroid cancer	2.59e-05	0.000404	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—AKT1—thyroid cancer	2.52e-05	0.000392	CbGpPWpGaD
